glutamic acid has been researched along with Diabetic Angiopathies in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fernandez, C; Melander, O; Ottosson, F; Smith, E | 1 |
Shiriaeva, IuK; Titov, VN | 1 |
Ishikawa, SE; Kawakami, M; Tamemoto, H | 1 |
Cai, H; Colagiuri, S; Wang, X; Wilcken, DE | 1 |
4 other study(ies) available for glutamic acid and Diabetic Angiopathies
Article | Year |
---|---|
Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes.
Topics: Aged; Aged, 80 and over; Asparagine; Case-Control Studies; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Glutamic Acid; Homeostasis; Humans; Male; Middle Aged; Prodromal Symptoms | 2018 |
[The glucose, glycotoxins and glycation products: the involvement into pathogenesis of microangiopathies, arteriolosclerosis and atherosclerosis].
Topics: Arteriolosclerosis; Atherosclerosis; Diabetes Mellitus; Diabetic Angiopathies; Glucose; Glutamic Acid; Glycation End Products, Advanced; Glycosylation; Glyoxal; Humans; Metabolic Networks and Pathways; Oxidation-Reduction; Proteolysis; Pyruvaldehyde; Vascular Diseases | 2011 |
Association of the Glu298Asp polymorphism of the eNOS Gene with ischemic heart disease in Japanese diabetic subjects.
Topics: Amino Acid Substitution; Aspartic Acid; Diabetic Angiopathies; DNA; Glutamic Acid; Glycated Hemoglobin; Humans; Japan; Myocardial Ischemia; Nitric Oxide Synthase Type III; Polymorphism, Restriction Fragment Length | 2008 |
A common Glu298-->Asp (894G-->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes.
Topics: Albuminuria; Amino Acid Substitution; Angina Pectoris; Aspartic Acid; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Exons; Genotype; Glutamic Acid; Humans; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peripheral Vascular Diseases; Point Mutation; Risk Factors | 1998 |